Overview

Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas

Status:
NOT_YET_RECRUITING

Trial end date:
2032-06-01

Target enrollment:

Participant gender:

Summary

This is phase II randomized, multicenter study of treatment with L-TC and preoperative HFRT in patients who were aged 18 years or older with documented localised or locally advanced soft-tissue sarcoma of the extremity. Eligible patients will be randomly assigned 2:1 to receive a preoperative HFRT alone (Arm A) or L-TC with preoperative HFRT (Arm B).

Phase:

PHASE2

Details

Lead Sponsor:

Institut de cancérologie Strasbourg Europe

Collaborator:

LEAF4Life, Inc.